Wolfe Research reiterated a Peerperform rating for Lyft (NASDAQ:LYFT) stock, maintaining a positive outlook as the company approaches its fourth-quarter earnings report set to be released on February ...

CNBC’s Seema Mody and Chris Senyek, Wolfe Research chief investment strategist, join 'Power Lunch' to discuss the Honeywell ...

Wolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating and $25 price target The stock’s current ...

Wolfe Research assumed coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research report report published on Tuesday morning, Marketbeat reports. The firm issued a ...

Wolfe Research analyst Shweta Khajuria says Roblox (RBLX) reported a “modest” bookings miss in Q4 versus Street estimates elevated investor expectations with EBITDA posting a slight beat.

Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of AnaptysBio (LSE:0HFQ) with a Outperform recommendation. What is the Fund Sentiment? There are 357 funds or ...

Fintel reports that on February 3, 2025, Wolfe Research upgraded their outlook for Northrop Grumman (WBAG:NOCO) from Underperform to Peer Perform. There are 2,442 funds or institutions reporting ...

Investment analysts at Wolfe Research assumed coverage on shares of 89bio (NASDAQ:ETNB – Get Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage set an ...

Wolfe Research initiated coverage of 89bio (ETNB) with an Outperform rating and $15 price target. Considering how low the stock is currently ...